Long-term survival outcomes with nivolumab (NIVO) in patients with previously treated advanced non-small cell lung cancer (NSCLC): Impact of early disease control and response Meeting Abstract


Authors: Wohlleber, M.; Brahmer, J.; Borghaei, H.; Ramalingam, S. S.; Horn, L.; Carpeño, J. D.; Pluzanski, A.; Burgio, M. A.; Garassino, M.; Chow, L. Q. M.; Gettinger, S.; Crino, L.; Planchard, D.; Butts, C.; Drilon, A.; Wojcik-Tomaszewska, J.; Otterson, G.; Agrawal, S.; Li, A.; Penrod, J. R.; Antonia, S. J.
Abstract Title: Long-term survival outcomes with nivolumab (NIVO) in patients with previously treated advanced non-small cell lung cancer (NSCLC): Impact of early disease control and response
Meeting Title: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie
Journal Title: Oncology Research and Treatment
Volume: 42
Issue: Suppl. 4
Meeting Dates: 2019 Oct 11-14
Meeting Location: Berlin, Germany
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2019-10-01
Start Page: 110
Language: English
ACCESSION: WOS:000568159600263
PROVIDER: wos
DOI: 10.1159/000502425
Notes: "Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology" -- Meeting Abstract: P406 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon